p53-mutant clones and field effects in Barrett's esophagus

Cancer Research

Volumn 59, Issue 19, 1999, Pages 4784-4787

  Prevo, Laura J ^a   Sanchez, Carissa A ^a   Galipeau, Patricia C ^a   Reid, Brian J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P53;

ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CELL MUTANT; CONTROLLED STUDY; DIPLOIDY; DNA DAMAGE; DNA SEQUENCE; EPITHELIUM DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; AMINO ACID SUBSTITUTION; BARRETT ESOPHAGUS; CLONING, MOLECULAR; ESOPHAGEAL NEOPLASMS; FRAMESHIFT MUTATION; GENES, P53; HUMANS; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033214611     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Devesa, S. S., Blot, W. J., and Fraumeni, J. F., Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer (Phila.), 83: 2049-2053, 1998.
2. Cameron, A. J., and Carpenter, H. A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am. J. Gastroenterol., 92: 586-591, 1997.
3. Witt, T. R., Bains, M. S., Zaman, M. B., and Martini, N. Adenocarcinoma in Barrett's esophagus. J. Thorac. Cardiovasc. Surg., 85: 337-345, 1983.
4. Neshat, K., Sanchez, C. A., Galipeau, P. C., Blount, P. L., Levine, D. S., Joslyn, G., and Reid, B. J. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology, 106: 1589-1595, 1994.
5. Hamelin, R., Flejou, J. F., Muzeau, F., Potet, F., Laurent-Puig, P., Fekete, F., and Thomas, G. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology, 107: 1012-1018, 1994.
6. Gleeson, C. M., Sloan, J. M., McGuigan, J. A., Ritchie, A. J., and Russell, S. E. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Cancer Res., 55: 3406-3411, 1995.
7. Blount, P. L., Galipeau, P. C., Sanchez, C. A., Neshat, K., Levine, D. S., Yin, J., Suzuki, H., Abraham, J. M., Meltzer, S. J., and Reid, B. J. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res., 54: 2292-2295, 1994.
8. Casson, A. G., Tammemagi, M., Eskandarian, S., Redston, M., McLaughlin, J., and Ozcelik, H. p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival. Mol. Pathol., 51: 71-79, 1998.
9. Barrett, M. T., Sanchez, C. A., Prevo, L. J., Wong, D. J., Galipeau, P. C., Paulson, T. G., Rabinovitch, P. S., and Reid, B. J. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet., 22: 106-109, 1999.
10. Reid, B. J., Blount, P. L., Rubin, C. E., Levine, D. S., Haggitt, R. C., and Rabinovitch, P. S. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology, 102: 1212-1219, 1992.
11. Paulson, T. G., Galipeau, P. C., and Reid, B. J. Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res., 9: 482-491, 1999.
12. Kusser, W. C., Levin, D. B., and Glickman, B. W. Sensitive two-stage PCR of p53 genomic DNA exons 5-9. PCR Methods Appl., 2: 250-252, 1993.
13. Gleeson, C. M., Sloan, J. M., McManus, D. T., Maxwell, P., Arthur, K., McGuigan, J. A., Ritchie, A. J., and Russell, S. E. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br. J. Cancer, 77: 277-286, 1998.
14. Casson, A. G., Mukhopadhyay, T., Cleary, K. R., Ro, J. Y., Levin, B., and Roth, J. A. p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res., 51: 4495-4499, 1991.
15. Ko, L. J., and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
16. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res., 56: 2488-2492, 1996.
17. Bedi, G. C., Westra, W. H., Gabrielson, E., Koch, W., and Sidransky, D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res., 56: 2484-2487, 1996.
18. Slaugher, D. P., Southwick, H. W., and Smejkal, W. "Field cancerization" in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
19. Goldstein, H. M., and Zornoza, J. Association of squamous cell carcinoma of the head and neck with cancer of the esophagus. Am J. Roentgenol., 131: 791-794, 1978.
20. Franklin, W. A., Gazdar, A. F., Haney, J., Wistuba, I. I., La Rosa, F. G., Kennedy, T., Ritchey, D. M., and Miller, Y. E. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis [published erratum appears in J. Clin. Investig., 100: 2639, 1997]. J. Clin. Investig., 100: 2133-2137, 1997.
21. Waridel, F., Estreicher, A., Bron, L., Flaman, J. M., Fontolliet, C., Monnier, P., Frebourg, T., and Iggo, R. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene, 14: 163-169, 1997.
22. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
23. Overholt, B. F., Panjehpour, M., and Haydek, J. M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest. Endosc., 49: 1-7, 1999.
24. Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C., and Vogelstein, B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.
25. Mao, L., Lee, J. S., Fan, Y. H., Ro, J. Y., Batsakis, J. G., Lippman, S., Hittelman, W., and Hong, W. K. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med., 2: 682-685, 1996.
26. Iwamoto, K. S., Mizuno, T., Kurata, A., Masuzawa, M., Mori, T., and Seyama, T. Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancers. Hum. Pathol., 29: 412-416, 1998.
27. Nagase, H., and Nakamura, Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum. Mutat., 2: 425-434, 1993.
28. 2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc. Natl. Acad. Sci. USA, 93: 7081-7084, 1996.